In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Whole exome sequencing of sporadic cerebellar hemangioblastoma

    Final Number:
    1437

    Authors:
    Luis Kolb; Ryan Matthew Hebert MD; Sacit Bulent Omay MD; Zeynep Erson Omay PhD; Akdes Serin; Victoria Elizabeth Clark; Ahmet Okay Caglayan; Kaya Bilguvar MD; Jie Li MD, PhD; Alexander O. Vortmeyer MD; Murat Gunel MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Cerebellar Hemangioblastomas of the CNS can occur sporadically or, frequently, as part of von Hippel-Lindau (VHL) syndrome. To date, genetic evaluation of sporadic hemagioblastomas has been limited to epigenetic and mutational characterization of the VHL gene, located in chromosome 3p. Mutations in the VHL gene are known to be associated with von Hippel-Lindau syndrome in autosomal dominant fashion.

    Methods: In an effort to further genetically characterize these lesions, we used whole-exome sequence analysis to study 16 blood matched sporadic hemangioblastomas tumor samples from patients without diagnosed von Hippel-Lindau syndrome.

    Results: Germline analysis confirmed the patients had no bloodline VHL gene mutations. Somatic analysis of the blood matched tumor pairs identified nine somatic VHL gene mutations (56%). Furthermore, copy number variant (CNV) analysis and LOH analysis found alterations in chromosome 3 in eleven of the 16 samples (69%). Only 2 of the 16 samples (13%) had neither a sporadic mutation of the VHL gene, CNV alterations or LOH at chromosome 3p.

    Conclusions: Our findings further confirm the involvement of the VHL gene and chromosome 3 mutations in this disease process, and underscore the importance of VHL pathway in sporadic hemangioblastomas.

    Patient Care: Further understanding the genetic profile of tumors, in this case hemangioblastomas, will help clinicians identify targeted therapies.

    Learning Objectives: By the conclusion of the session, participants should be able to: 1) Better understand the genetic profile of hemangioblastomas. 2) Understand the relationship between sporadic cerebellar hemangioblastomas and mutations in the VHL gene and chromosome 3.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy